Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2025-12-24 @ 10:41 PM
NCT ID:
NCT00402935
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of cancer, including, but not limited to, any of the following:
* Acute lymphocytic leukemia
* Acute myeloid leukemia
* Hodgkin's lymphoma
* Must have primary disease with significant chance for long-term survival after therapy
* Scheduled to receive chemotherapeutic agents known to be associated with ovarian failure, including any of the following:
* Cyclophosphamide
* Mechlorethamine hydrochloride
* Busulfan
* Procarbazine hydrochloride
* Chlorambucil
* Melphalan
* Ifosfamide
* Cisplatin
* Carboplatin
* Postmenarchal and premenopausal
PATIENT CHARACTERISTICS:
* Female
* Weight ≤ 250 pounds
* Not pregnant
PRIOR CONCURRENT THERAPY:
* No prior or concurrent total-body irradiation or radiotherapy to the pelvis
* Concurrent bone marrow transplantation allowed
* Concurrent oral contraception and/or gonadotropin releasing-hormone analogue allowed
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
14 Years
Maximum Age:
35 Years
Study:
NCT00402935
Study Brief:
Protocol Section:
NCT00402935